证券代码：688399 证券简称：硕世生物 公告编号：2026-004 江苏硕世生物科技股份有限公司 预计 2025 年度归属于母公司所有者的扣除非经常性损益的净 利润为-8,190 万元到-12,280 万元，与上年同期（法定披露数据）相 比，将扩大亏损 1,006.29 万元到 5,096.29 万元。 2025 年年度业绩预告 一、本期业绩预告情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 重要内容提示： 经财务部门初步测算，预计 2025 年度实现归属于母公司所有 者的净利润为-2,940 万元到-4,400 万元，与上年同期（法定披露数 据）相比，将扩大亏损 2,739.83 万元到 4,199.83 万元。 （二）2024 年度基本每股收益为-0.02 元(该数据为追溯调整后 金额，公司于 2025 年 6 月实施 2024 年度权益分派，以资本公积金向 全体股东每 10 股转增 4.8 股，根据《企业会计准则第 34 号——每股 收益》，因股本变动需追溯调整往期每股收益，原披露的 2024 年度 基本 ...

证券代码：002424 证券简称：ST 百灵 公告编号：2026-008 贵州百灵企业集团制药股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 三、业绩变动原因说明 2025 年度，公司整体经营保持稳定态势，但受产品市场需求放缓、医 保支付政策调整及市场竞争加剧等因素影响，叠加产业链各环节产能供需变 化、库存压力等因素，行业整体利润承压，2025 年度公司营业收入同比下 降约 20%，加上公司固定资产规模扩大，折旧摊销费用增加，当期固定成本 上升，对当期业绩造成一定影响，致使归属于上市公司股东的净利润及扣除 非经常性损益的净利润同比均出现下滑。 2026 年度，虽然公司经营面临行业周期波动等诸多挑战，但公司将持 续推进发展战略目标，以积极应对医药行业复杂多变的环境。公司一方面将 积极扩展主导产品的市场销售和持续优化产品结构，努力扩大市场份额。另 一方面，公司将通过持续投入研发项目来丰富产品管线，加快研发项目的上 市节奏。同时进一步加强合规管理工作，有效降低各类风险的发生。 1、业绩预告期间：2025 年 1 月 1 日至 2 ...

Financial Performance - The company expects a net profit of approximately -19,000万元 for the year 2025, compared to -13,000万元 in the same period last year[2] - The net profit after deducting non-recurring gains and losses is projected to be around -22,000万元, an improvement from -25,635.99万元 year-over-year[3] - Basic earnings per share are estimated at -0.2566元, compared to -0.3002元 in the previous year[3] Impairment and Provisions - The company plans to recognize impairment provisions for inventory, goodwill, and receivables totaling between 90,000万元 and 120,000万元[5] Business Operations - Despite a challenging market environment, the company's main business revenue has shown growth due to enhanced operational efficiency and cost reduction measures[5] - The company is undergoing strategic adjustments and restructuring, which has led to revenue declines in some business units[6] Financial Reporting - The financial data provided is preliminary and subject to final confirmation in the 2025 annual report, highlighting potential investment risks[7]

证券简称：上海电力 证券代码：600021 编号：临 2026-007 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 上海电力股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 1.公司预计2025年度实现归属于上市公司股东的净利润为25.11亿元到 29.88亿元。与上年同期（法定披露数据）相比，将增加4.65亿元到9.42亿元， 同比增加22.71%到46.03%。 2. 公司2025年度实现归属于上市公司股东的扣除非经常性损益的净利润预 计为23.50亿元到27.97亿元。与上年同期（法定披露数据）相比，将增加4.55 亿元到9.02亿元，同比增加24.03%到47.60%。 一、本期业绩预告情况 （一）公司扎实开展提质增效工作，强化全要素挖潜，燃料成本、资金成本 等持续下降。 经财务部门初步测算，公司预计 2025 年度实现归属于上市公司股东的净利 润为 25.11 亿元到 29.88 亿元。与上年同期（法定 ...

Financial Performance Expectations - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between 7.20 million and 10.80 million yuan, an increase of 15.01 million to 18.61 million yuan compared to the previous year, achieving a turnaround from loss to profit [3]. - The net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is expected to be between -14.50 million and -11.00 million yuan, an increase of 5.06 million to 8.56 million yuan compared to the previous year [3]. - The total profit for 2024 was -15.22 million yuan, with a net profit attributable to shareholders of the parent company at -7.81 million yuan [4]. Cost Management and Efficiency - The company implemented cost reduction and efficiency enhancement measures, leading to a year-on-year decrease in period expenses [5]. - The company strengthened accounts receivable management, recovering some receivables from previous years and reversing some impairment losses [6]. Earnings Forecast Validity - The financial data in the earnings forecast has not yet been audited by a registered accountant [7]. - There are no significant uncertainties affecting the accuracy of the earnings forecast as of the announcement date [7]. - The earnings forecast data is preliminary and subject to change based on the audited annual report to be disclosed later [8].

Financial Projections - The company expects a total profit loss of between -83 million and -65 million yuan for the year 2025, with a net profit attributable to shareholders of -84 million to -66 million yuan [3]. - Estimated operating revenue for 2025 is projected to be between 360 million and 410 million yuan, with the same range applicable after excluding unrelated business income [3]. - The net assets at the end of 2025 are expected to be between 850 million and 940 million yuan [3]. Previous Year Performance - The previous year's total profit was -23.93 million yuan, with a net profit attributable to shareholders of -23.47 million yuan [6]. Revenue and Cost Factors - The company experienced a significant increase in operating revenue due to the inclusion of Dalian Yiwei New Materials Co., Ltd., contributing approximately 140 million yuan [7]. - The decline in export revenue from ceramic products and increased costs due to lower export tax rebates have negatively impacted gross profit and margins [7]. - The company has faced increased foreign exchange losses due to fluctuations in the USD, affecting overall profitability [7]. Asset and Impairment Issues - There are indications of asset impairment, leading to increased provisions for impairment losses on fixed assets and inventory [7]. Regulatory and Audit Concerns - The company’s stock has been placed under delisting risk warning due to negative profit indicators as per the Shanghai Stock Exchange regulations [4]. - The financial data provided is preliminary and subject to final audit confirmation in the annual report [10].

证券代码：688207 证券简称：格灵深瞳 公告编号：2026-002 北京格灵深瞳信息技术股份有限公司 2025 年年度业绩预亏公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 1、经财务部门初步测算，预计北京格灵深瞳信息技术股份有限公司（以下 简称"公司"）2025 年年度实现营业收入 12,000 万元到 16,000 万元，与上年同期 （法定披露数据，下同）相比增长 2.35%至 36.47%。 2、经财务部门初步测算，预计公司 2025 年年度实现归属于母公司所有者的 净利润为-24,000 万元到-17,000 万元，与上年同期相比亏损增加 13.42%到亏损减 少 19.66%。 3、经财务部门初步测算，预计公司 2025 年年度实现归属于母公司所有者扣 除非经常性损益后的净利润为-25,000 万元到-18,000 万元，与上年同期相比亏损 增加 10.36%到亏损减少 20 ...

经文投控股股份有限公司（以下简称"公司"）财务部门初步测算，预 计公司 2025 年度实现营业收入 30,500 万元至 33,000 万元，实现扣除与主营业 务无关的业务收入和不具备商业实质的收入后的营业收入 30,500 万元至 33,000 万元；预计公司 2025 年度实现归属于上市公司股东的净利润-4,000 万元至 -6,000 万元，实现归属于上市公司股东的扣除非经常性损益后的净利润-4,000 万元至-6,000 万元。 证券代码：600715 证券简称：文投控股 编号：2026-002 文投控股股份有限公司 2025 年年度业绩预亏公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 业绩预告的具体适用情形：净利润为负； 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二） 业绩预告情况 经公司财务部门初步测算，预计公司 2025 年度实现营业收入 30,500 万元至 33,000 万元，实现扣除与主营业务无关的业务收入和不具备 ...

证券简称：广东明珠 证券代码：600382 编号：临 2026-004 广东明珠集团股份有限公司 2025 年年度业绩预增公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●本期业绩预告适用于实现盈利，且净利润与上年同期相比上升 50%以上的 情形。 ●经广东明珠集团股份有限公司（以下简称"公司"）财务部门初步测算， 预计公司2025年实现归属于母公司所有者的净利润16,569.17万元到20,251.20 万元，与上年同期（法定披露数据）相比，预计将增加 16,018.42 万元到 19,700.45 万元，同比增长 2,908.49%到 3,577.04%。预计公司 2025 年实现归属于母公司所 有者的扣除非经常性损益的净利润 17,457.72 万元到 21,337.21 万元，与上年同 期（法定披露数据）相比，预计将增加 14,117.11 万元到 17,996.60 万元，同比 增长 422.59%到 538.72%。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2 ...

Financial Performance Expectations - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -98 million and -185 million yuan, indicating a loss [3]. - The expected net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between -106 million and -196 million yuan [5]. - The total profit for the same period last year was -100.54 million yuan [6]. - The net profit attributable to shareholders of the parent company for the same period last year was -65.60 million yuan [7]. Impairment and Operational Challenges - The company plans to recognize an impairment loss of 163 million yuan on long-term assets of its subsidiary, Guohua Jintai, contributing to the increased expected loss [8]. - The photovoltaic industry has not shown significant recovery, with product prices remaining low, impacting the company's glass business [8]. - The production costs of Guohua Jintai's glass project exceeded expectations due to the need to purchase most of the ultra-white sand raw materials externally [8]. Capital Increase and Financial Stability - The company is currently undergoing a targeted capital increase, which is critical for maintaining operations and avoiding production halts due to financial strain [9]. - The company warns that failure to complete the capital increase may lead to increased asset impairment and larger losses [10]. - The company emphasizes that the expected performance data is preliminary and subject to final audit confirmation in the 2025 annual report [11].